Filing Details
- Accession Number:
- 0000950170-23-065125
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-20 16:30:12
- Reporting Period:
- 2023-11-16
- Accepted Time:
- 2023-11-20 16:30:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1521036 | Lantheus Holdings Inc. | LNTH | In Vitro & In Vivo Diagnostic Substances (2835) | 352318913 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1801395 | Paul Blanchfield | C/O Lantheus Holdings, Inc. 201 Burlington Road, South Building Bedford MA 01730 | President | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-11-16 | 1,500 | $67.96 | 88,651 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2023.
- Includes 84 shares acquired under the LNTH employee stock purchase plan on September 13, 2023.
Billionaire Hedge Funds
